000504 南華生物
按盤價 
9.700 -0.350 (-3.483%)
9.700 -0.350 (-3.483%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.327 | -20.795 | -81.291 | -88.528 | 36.260 |
| 總資產報酬率 ROA (%) | -1.232 | -4.253 | -2.055 | -3.147 | 1.978 |
| 投入資產回報率 ROIC (%) | -1.868 | -8.426 | -6.075 | -12.780 | 3.605 | 邊際利潤分析 |
| 銷售毛利率 (%) | 68.033 | 68.063 | 64.792 | 70.831 | 55.525 |
| 營業利潤率 (%) | -8.068 | -33.419 | -13.052 | -19.579 | 10.790 |
| 息稅前利潤/營業總收入 (%) | -8.342 | -26.025 | -4.978 | -10.368 | 12.679 |
| 淨利潤/營業總收入 (%) | -9.615 | -34.198 | -14.704 | -21.135 | 8.336 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 36.794 | 46.053 | 32.101 | 62.241 | 104.845 |
| 價值變動淨收益/利潤總額(%) | -26.856 | -2.133 | 0.255 | 1.033 | -1.192 |
| 營業外收支淨額/利潤總額(%) | 0.249 | -2.246 | -21.290 | -1.447 | 0.127 | 償債能力分析 |
| 流動比率 (X) | 1.832 | 1.448 | 0.915 | 0.977 | 1.147 |
| 速動比率 (X) | 1.759 | 1.424 | 0.905 | 0.956 | 1.111 |
| 資產負債率 (%) | 49.300 | 60.503 | 85.509 | 83.266 | 75.819 |
| 帶息債務/全部投入資本 (%) | 41.169 | 40.105 | 85.157 | 81.178 | -- |
| 股東權益/帶息債務 (%) | 134.886 | 141.467 | 7.621 | 10.552 | 35.384 |
| 股東權益/負債合計 (%) | 84.896 | 55.054 | 2.961 | 3.031 | 6.301 |
| 利息保障倍數 (X) | 32.878 | -3.907 | -0.861 | -1.161 | 6.760 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 368.759 | 371.056 | 318.839 | 442.373 | 0.000 |
| 存貨周轉天數 (天) | 138.194 | 62.467 | 38.635 | 100.751 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
